Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-19T06:36:20.928Z Has data issue: false hasContentIssue false
  • English
  • Français

Dangerous Liaisons? Industry Relations with Health Professionals

Published online by Cambridge University Press:  01 January 2021

Robert M. Sade
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Introduction
Information
Journal of Law, Medicine & Ethics , Volume 37 , Issue 3 , Fall 2009 , pp. 398 - 400
Copyright
Copyright © American Society of Law, Medicine and Ethics 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Price, P. B., Taylor, C. W. and Nelson, D. E. et al. Measurement and Predictors of Physician Performance: Two Decades of Intermittently Sustained Research (Salt Lake City: Aaron Press, 1971): 121–149.Google Scholar
Sade, R. M., Stroud, M. R., Levine, J. H. and Fleming, G. A., “Criteria for Selection of Future Physicians,” Annals of Surgery 201, no. 2 (1985): 225–230.CrossRefGoogle Scholar
Council on Ethical and Judicial Affairs of the American Medical Association, “Gifts to Physicians from Industry,” JAMA 265, no. 4 (1991): 501.CrossRefGoogle Scholar
Olivieri, N. F., Brittenham, G. M., McLaren, C. E., Templeton, D. M., Cameron, R.G., McClelland, R. A., Burt, A. D. K. A. and Fleming, K. A., “Long-term Safety and Effectiveness of Iron-Chelation Therapy with Deferiprone for Thalassemia Major,” New England Journal of Medicine 339, no. 7 (1998): 417–423.CrossRefGoogle Scholar
Kondro, W., “Canadian Panel Calls for Review of Drug-trial Confidentiality Agreements,” The Lancet 352, no. 9145 (1998): 1996.CrossRefGoogle Scholar
Shuchman, M., “Independent Review Adds to Controversy at Sick Kids,” Canadian Medical Association Journal 160, no. 3 (1999): 386–368.Google Scholar
Stelfox, H. T., Chua, G., O'Rourke, K. and Detsky, A. S., “Conflict of Interest in the Debate over Calcium-Channel Antagonists,” New England Journal of Medicine 338, no. 23 (1998): 101–106.CrossRefGoogle Scholar
Bodenheimer, T., “Uneasy Alliance – Clinical Investigators and the Pharmaceutical Industry,” New England Journal of Medicine 342, no. 20 (2000): 1539–1544.CrossRefGoogle Scholar
Angell, M., “Is Academic Medicine for Sale?” New England Journal of Medicine 342, no. 20 (2000): 1516–1518.CrossRefGoogle Scholar
Wazana, A., “Physicians and the Pharmaceutical Industry: Is a Gift Ever just a Gift?” JAMA 283, no. 20 (2000): 373–380.CrossRefGoogle Scholar
Stossel, T. P., “Regulating Academic-Industrial Research Relationships – Solving Problems or Stifling Progress?” New England Journal of Medicine 353, no. 10 (2005): 1060–1065.CrossRefGoogle Scholar
Brennan, T. A., Rothman, D. J., Blank, L., Blumenthal, D., Chimonas, S. C., Cohen, J. J., Goldman, J., Kassirer, J. P., Kimball, H., Naughton, J. and Smelser, N., “Health Industry Practices that Create Conflicts of Interest: A Policy Proposal for Academic Medical Centers,” JAMA 295, no. 4 (2006): 429–433.CrossRefGoogle Scholar